NEWS
|
HEALTH SCIENCE
Duke researcher Louise Markert receives FDA approval for groundbreaking treatment of pediatric immune disorder
By Velda Wang | November 1, 2021The groundbreaking therapy is the only available treatment for pediatric congenital athymia patients.